NMR chemical shift and relaxation measurements provide evidence for the coupled folding and binding of the p53 transactivation domain von Vise, Pamela D., Baral, Bharat, Latos, Andrew J., Daughdrill, Gary W.

Volltext

Overlapping H–N HSQC spectra for A59 and A128 resonances obtained during titration between hRPA70 and p53TAD von Vise, Pamela D., Baral, Bharat, Latos, Andrew J., Daughdrill, Gary W.

Volltext bestellen

() Ribbon diagram of DBD F showing the position on the structure of residues with the largest chemical shift changes upon binding p53TAD colored red von Vise, Pamela D., Baral, Bharat, Latos, Andrew J., Daughdrill, Gary W.

Volltext bestellen

Linear schematic diagrams showing the functional domains of hRPA70 and p53 von Vise, Pamela D., Baral, Bharat, Latos, Andrew J., Daughdrill, Gary W.

Volltext bestellen

Plots showing secondary chemical shifts for p53TAD based on resonance assignments obtained at 298K von Vise, Pamela D., Baral, Bharat, Latos, Andrew J., Daughdrill, Gary W.

Volltext bestellen

Plots of reduced spectral density mapping data for p53TAD (open circles) and p53TAD plus unlabeled hRPA70 (closed circles) von Vise, Pamela D., Baral, Bharat, Latos, Andrew J., Daughdrill, Gary W.

Volltext bestellen

Selected regions of the assigned H–N HSQC spectra of 0 von Vise, Pamela D., Baral, Bharat, Latos, Andrew J., Daughdrill, Gary W.

Volltext bestellen

Model for p53–hRPA70 disassociation von Vise, Pamela D., Baral, Bharat, Latos, Andrew J., Daughdrill, Gary W.

Volltext bestellen

Plots showing relaxation data for p53TAD (open circles) and p53TAD plus unlabeled hRPA70 (closed circles) von Vise, Pamela D., Baral, Bharat, Latos, Andrew J., Daughdrill, Gary W.

Volltext bestellen

The calculated intensity ratios for p53TAD after the addition of () hRPA70, () R41E and () Y118A von Vise, Pamela D., Baral, Bharat, Latos, Andrew J., Daughdrill, Gary W.

Volltext bestellen

Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's p... von Gligorov, J, Ataseven, B, Verrill, M, De Laurentiis, M, Jung, K.H, Azim, H.A, Al-Sakaff, N, Lauer, S, Shing, M, Pivot, X

Volltext

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification von National Kidney Foundation

Volltext